Among injection drug users, human immunodeficiency virus (HTV) is mainly transmitted via the sharing of needles and syringes, although sexual transmission also occurs (1) (2) (3) . Within the group of injection drug users, sexual transmission has gained importance because reductions in sexual risk behavior were small (4-6) compared with reductions in injection risk behavior (3, (7) (8) (9) (10) . This may especially apply to noncommercial (private) sexual contacts during which condom use is much lower than during commercial sexual contacts, though this may be outweighed by the higher number of commercial partners (11) (12) (13) .
Injection drug users play an important role with regard to the heterosexual spread of HTV toward the group of non-injecting heterosexuals (12, 14) . This problem is not expected to be resolved by itself in the next decade owing to an exhaustion of the group of HIV-positive injection drug users, because it seems very difficult to reduce injection risk behavior to a level at which no new HTV infections will occur (15). In addition, the prevention of initiation of injection among drug users appears to be difficult (16, 17) . With regard to HTV transmission to the general population, male injection drug users may be relatively important, because they report more often than do female injection drug users that they have non-injection private partners, and there are more male than female injection drug users (12) . In addition, the likelihood of sexual transmission of HTV appears to be higher from males to females than vice-versa (18) .
Previous studies have indicated small reductions in sexual risk behavior, but only a few studies have reported on long-term behavioral trends. Moreover, several of these studies are hard to interpret because details on sexual behavior are lacking (e.g., with regard to condom use and number of sexual partners, no distinction is made between regular, casual, and commercial sexual contacts). The present study is part of a comprehensive cohort study among drug users in Amsterdam, the Netherlands. We have already reported on a large reduction in commercial sexual risk behavior among drug-using prostitutes (13) . In this paper, longterm trends in sexual behavior with regard to noncommercial partners are described in a large group of heterosexual injection drug users in Amsterdam.
Trends are determined in subgroups with the use of detailed data on sexual behavior and characteristics of steady partners. It appeared that large reductions in sexual risk behavior with noncommercial partners have occurred in specific subgroups that are at highest risk to acquire or transmit HTV. In addition, the actual risk for further transmission of HTV via heterosexual contact is lower than previously reported owing to nonrandom mixing.
MATERIALS AND METHODS
In December 1985, an open cohort study (continuous recruitment of new participants) among drug users was started in Amsterdam (10, 11, (19) (20) (21) . Participants are required to be free of acquired immunodeficiency syndrome (AIDS) at intake. Recruitment is via methadone posts, a sexually transmitted disease (STD) clinic for addicted prostitutes, and by word of mouth. Participation in the study is voluntary, and informed consent is obtained. Participants are asked to return every 4 months for follow-up visits. At every visit, blood is drawn, and a standardized questionnaire is administered by specially trained nurses. At intake, questions regarding current behavior refer to the 6-month period preceding the intake, while at followup visits these questions refer to the period between present and preceding visit. Blood specimens are tested for HTV by enzyme-linked immunosorbent assay, and positive specimens are confirmed by immunoblotting (19) .
Sexual behavior of Amsterdam drug users may have been influenced by several factors. Apart from general attention in the media given to AIDS and HTVinfection, formal mass media campaigns began in 1987 that promote condom use. Locally instituted initiatives in Amsterdam include HTV-counseling, HTVtesting, spread of leaflets in various languages, and specifically for drug-using prostitutes there is an STDclinic and distribution of free condoms. In principle, participants in our cohort study are counselled at every study visit and they can receive the HTV-test result and post-test counseling 3 weeks or later after a visit, or at the following study visit. In the early years of the study, we allowed participants not to learn HTV serostatus. Still, only a few participants (<5 percent) are unaware of their HTV-serostatus at follow-up visits. At intake visits, there is a gradual increase in the proportion who already received a prior HTV-test result (29 percent in 1989 to 59 percent in 1994) (22) .
For the purposes of the present study, only those visits were selected that were made after April 1989, because questions on current sexual behavior with private partners were added at that time. Since April 1989, the questionnaire has not been changed. Participants were selected who had a history of injection and who denied that they have engaged in homosexual behavior since 1980. The study period ended in May 1995.
The current sexual behaviors that were used as outcomes are shown in table 1. A sexual partner is defined as a partner of the opposite sex with whom the participant has had vaginal sexual contact. The distinction between a regular and casual partner is subjective and made by the participant her/himself. In case of more than one regular partner since the preceding visit, questions are only asked concerning the most recent partner. Condom use only refers to vaginal sexual contacts and not to oral or anal contacts.
Trends per calendar year are determined using all visits of all participants. Unfortunately, numbers of new recruits were too small from 1989 onward to permit a separate analysis using only intake visits. The use of intake visits alone has the advantage that an observed risk reduction can not be explained by a study effect, i.e., at subsequent cohort visits the unwillingness to admit the same risk behaviors may increase (socially desirable answering) and participation in the study may be protective (e.g., the counseling component). A previous study in our cohort has already shown that underreporting of STDs is more related to number of cohort visits than calendar year (23) . To deal with this problem, trends were stratified by number of cohort visits, as the mean number of cohort visits strongly increased in calendar time. As a result, the adjusted trends in time are more generalizable to drug users in Amsterdam as a whole. In contrast to these trends, however, the absolute levels of risk behavior will most probably be underestimated because of this study effect (the mean number of cohort visits in the study sample was 9.2).
Apart from number of follow-up visits, trends in the outcome variables are also multivariately adjusted for other general characteristics and current behavior that showed trends in time (table 2) . In addition, we determined whether the trends in time were different in subgroups by evaluating the first order interaction terms between these variables and calendar year. Theoretically, adjustment of trends in time for current behavior might lead to overmatching, because current behavior (which is related to the outcomes) may be influenced by AIDS-prevention measures. However, it appeared that adjustment for current behaviors only led to minor changes in the estimates for the magnitude of trends in sexual risk behavior.
Observations within one individual are not independent but positively interrelated. To adjust for this, generalized estimating equations (GEE) were used to analyze these repeated measures (24) (25) (26) . An exchangeable autocorrelation structure was used in which it is assumed that the correlation between behavior within one person does not depend on the relative distance between cohort visits made by that person. The outcomes were dichotomized, and a logit link function (logistic regression) was used. Univariate trends in time in continuous variables (age, number of cohort visits, and duration of residence in Amsterdam) were tested using a linear link function. Testing was done two-sided and p values < 0.05 were considered significant
RESULTS

From
April 1989 through May 1995, 5,214 visits were made by a total of 653 heterosexual injection drug users. Of these 653 drug users, 42 percent were female, 69 percent had Dutch nationality, and 16 percent German nationality. For 326 injection drug users (50 percent), the first visit they made during the study period was also the first time they attended the cohort study. At the first selected visit, 33 percent were HIVpositive, 69 percent used daily methadone, and 76 percent currently injected. Mean ages were 33.4 years among men and 30.6 years among women. A history of prostitution was reported by 83 percent of females. Table 1 shows the crude trends in the outcome variables from 1989 through 1995. In general, a larger risk reduction was observed with regard to casual than regular partners. The decrease in having a regular partner was not significant and the decrease in inconsistent condom use with regular partners was significant but small. With regard to casual partners, consistent condom use strongly increased from 24 to 46 percent, whereas a significant decline from 25 to 16 percent in having a casual partner was observed.
Trends in calendar time
Of regular partners, 35 percent had no history of drug use, 15 percent had only used drug non-parenterally, 16 percent had injected over 6 months ago, and 34 percent currently injected. Of the participants, 37 percent were unaware of the HTV-serostatus of their regular partners, and 16 and 47 percent, respectively, knew thenpartner to be HIV-positive and HTV-negative. No important changes in time in characteristics of regular partners were reported.
It appeared that several characteristics of participants of our cohort study changed in time (table 2) . Statistically significant decreases were observed with regard to the proportion who were female, having a German nationality, having a West European ethnicity, not being aware of one's own HTV serostatus, current prostitution, currently injecting, frequency of injection, and current parenteral amphetamine use. A significant increase in time is found in having symptomatic HTV-infection, age, number of cohort visits, and number of years of residence in Amsterdam.
The trends in the outcome variables may be influenced by these changes in characteristics of the study group. It appeared that there was considerable confounding by the increasing number of cohort visits, which is shown in figure 1 by stratifying trends in four selected outcomes for categories of number of cohort visits (for simplicity, calendar year and number of cohort visits were recoded in three categories). Except for the outcome "having a regular partner," the inverse relation between high-risk behavior and number of cohort visits appears stronger than the effect of calendar time on the outcomes. We estimated the crude and adjusted effect sizes of calendar year (continuous) and number of cohort visits (in five categories (see table 3)) using multivariate models. Indeed, the effects of calendar year on the risk behaviors studied became considerably weaker and were no longer significant, except for the decrease in inconsistent condom use with casual partners (p -0.05). On the other hand, when adjustment was made for calendar time, injection drug users with more follow-up visits reported less often that they had a casual partner and much lower levels of inconsistent condom use with regular and casual partners. The odds ratios in table 3 did not substantially change after adjustment for other general characteristics and current behavioral variables.
To study whether trends differed per subgroup (according to the variables in table 2), interaction terms were determined between these variables and calendar year with the use of multivariate models. The only significant differences in trends were found for the variable "knowledge of HTV serostatus." In contrast to injection drug users who were known to be HTVnegative, known HTV-positives reported major and significant declines in having a regular or casual partner, and also when these trends were adjusted for number of cohort visits. This is shown in table 4, together with the stratified trends (the group with serostatus unknown was too small to provide meaningful figures). Trends in time did not significantly differ between known positives and negatives with regard to condom use with regular or casual partners. Still, among known HTV-positives, the decrease in inconsistent condom use with regular partners became significant, whereas among HTV-negatives it is not significant. Additionally, a significant decline in inconsistent condom use with casual partners appeared to be present only for known HTV-negatives, although the absolute level of this risk behavior remains lower among known HTV-positives. • p < 0.05. t Calendar year and number of cohort visits were put simultaneously into the model. Number of cohort visits was receded Into categories to apply with the expected nonexponerrUal effect (1 = visit 1; 2 -visits 2-3; 3 = visits 4-7; 4 = visits 8-12; 5 = visit 13 and higher), and this receded variable and calendar year are put continuously into the models. Generalized estimating equations (GEE) were used for Inference (see Materials and Methods).
t OR, odds ratio; Cl, confidence interval.
The decline in inconsistent condom use was largest in regular sexual relationships in which the partners were aware of having discordant HTV serostatus (table  4) . Participants in our study who knew they were HIV-positive significantly reduced inconsistent condom use both with known HIV-positive partners (from 87 to 50 percent) and known negative regular partners (from 48 to 15 percent). These trends remained significant after adjustment for number of cohort visits. Participants in our study who knew they were HTVnegative reduced inconsistent condom use only when they knew their regular partner was HIV-positive, from a high of 67 percent in 1989 to only 14 percent in 1995. This trend, adjusted for number of cohort visits, was strong (odds ratio = 0.70 per year) but statistically not significant.
Additional adjustment of the association between calendar year and the four outcomes for general characteristics and current behavioral variables did not substantially change the results (table 4) .
It may be that the decline in inconsistent condom use among HTV-discordant couples was caused by an exhaustion of the high-risk group, i.e., HTV-negative persons in discordant couples with inconsistent condom use may seroconvert for HTV by sexual transmission and will become concordant. Therefore, the data of initially HTV-negative participants were reanalyzed in such a way that those who seroconverted remained included as an HTV-discordant couple when determining the trends. This did not lead to different results.
These declines in risk behavior may be caused by a selective loss to follow-up of injection drug users who are less motivated to reduce risk behavior. To gain insight into this, trends in the outcomes were compared for the group of injection drug users who were lost (defined as having been recruited before January 1, 1993 and not having made a follow-up visit after January 1, 1994) and not lost (recruited before January 1, 1993 and having made a visit after this). No substantial differences in trends were observed. Table 5 shows the interrelations between the outcomes, characteristics of regular partners, three general characteristics, and participant's knowledge of HTV-seropositivity. Associations were considered important only when correlation coefficients exceeded 0.15, because almost all associations were statistically significant when using GEE because of the high number of observations. First, injection drug users with a regular partner reported less often that they had a casual partner compared with injection drug users without a regular partner (11 vs. 24 percent). Among drug users with both a regular and casual partner, those who reported inconsistent condom use with their regular partner also more often reported inconsistent condom use with casual partners (67 vs. 47 percent). Knowledge of the HTV-seropositivity of one's partner was much higher for injection than non-injection regular partners (38 vs. 5 percent). Participants knew the serostatus of only 39 percent of regular partners who had no history of injection drug use compared with 86 percent of partners who had a history of injection.
Mixing patterns
Female injection drug users compared with male injection drug users were much more likely to have a regular partner (61 vs. 30 percent) and to report higher levels of inconsistent condom use with casual partners (70 vs. 47 percent). Because the mean age of females is lower than males for all drug users, this is in accordance with the finding that injection drug users t OR, odds ratio; Cl, confidence interval § Percentages are based on yearly number of cohort visits, not on individuals.
U Parentheses Indicate group size on which the percentage is calculated is less than 10. who are older less often have a regular partner (age <30 years, 55 percent; age 30-39 years, 41 percent; and age >39 years, 29 percent). Among participants who have a regular partner, current injectors reported much more often that their regular partner also currently injected (50 percent vs. 7 percent) and that their regular partner was known to be HIV-positive. As discussed above, participants who knew they were HIV-positive less often reported inconsistent condom use with both regular and casual partners. Among participants with a regular partner, knowledge of one's own seropositivity was associated with having a known seropositive partner and having a currently injecting partner. Only 9 percent of known negative participants had a known positive partner compared with 30 percent of known positive participants. Table 4 shows that among injection drug users who had a regular partner whose serostatus was unknown, levels of inconsistent condom use remained high and stable-about 55 percent among known positive participants (who may transmit HTV-infection) and about 85 percent among known negative participants (who may acquire HTV-infection). However, among known HTVnegative participants, only 12 percent of their partners whose serostatus was unknown had a history of injection, which suggests that these participants run a relatively small risk of acquiring HTV-infection, because not many of these partners will be HTV-infected. Among participants who knew they were HIV-positive, the percent of partners with unknown serostatus who had a history of injection was significantly higher (29 percent).
DISCUSSION
In many previous studies, it has been shown that there is large potential for further spread of HTV via sexual transmission, both within the group of injection Am J Epidemiol Vol. 144, No. 8, 1996 drug users and from injection drug users to the general population (11, 12, (27) (28) (29) (30) (31) (32) (33) . In addition, the majority of injection drug users only showed small reductions in sexual risk behavior with noncommercial partners. However, the present study, shows 1) that large reductions in sexual risk behavior with noncommercial partners are possible and 2) that the actual risk for further transmission of HTV via heterosexual contact appears lower than previously reported. The reasons for our different findings are that longer-term trends were determined and that more detailed data on sexual behavior were available, especially knowledge of the HTV-serostatus of both the study participants and thenregular sex partners. Future studies should collect more detailed information on type of heterosexual partner (regular, casual, or commercial), the number of partners, and condom use (by type of partner) both for study participants and their partners, knowledge of serostatus, and injection history.
With regard to trends in time from 1989 through 1995, risk reduction appears to have selectively occurred in high-risk relationships, whereas in the total group the trends showed little change. First, there was a decrease in the proportion of injection drug users who reported that they had a regular and a casual partner. This decrease was confined to participants who had received a positive HTV-test result. Second, among HTV-discordant couples who had a regular relationship, inconsistent condom use selectively decreased to only 15 percent in 1995. Inconsistent condom use among known HTV-negatives with other partners remained high and stable at about 85 percent. Inconsistent condom use also decreased among known HIV-positive participants who had a known positive regular partner, which suggests that the prevention message that reinfection with HTV may accelerate disease progression has been effective. Third, among known HTV-negatives, inconsistent condom use with casual partners decreased, although the absolute level was still higher among known HTV-negatives than among known HTV-positives.
Apart from nonrandom condom use (highest among HIV-discordant couples), there also appeared to be nonrandom mixing (selective partner choice), which slows down the spread of HIV (31) . First, HIV-positives less often had a regular and casual partner than HTV-negatives. Second, among injection drug users who had a regular partner, only 9 percent of known HTV-negatives had a partner who was known to be positive, compared with 30 percent among known HIV-positives. Third, among HIVnegative participants who had a regular partner whose serostatus was unknown, 85 percent inconsistently used condoms. However, of these regular partners, only 12 percent reported a history of injection, and HTV prevalence among non-injectors was very low in Amsterdam (see below). Among known HIV-positive participants whose regular partners were of unknown serostatus, 29 percent of these partners had a history of injection. Fourth, currently injecting participants were much more likely to have a regular partner who was also currently injecting. Finally, when trends were adjusted for potential confounders, we found that symptomatic HTV-infected injection drug users compared with asymptomatic HIV-positives were less likely to have a regular partner, and they less often reported inconsistent condom use with regular and casual partners (data not shown). This is also expected to slow down the spread of HTV, because infectiousness is higher during late infection (32) .
Mixing and condom use was also nonrandom with respect to gender. Table 5 shows that female injection drug users compared with male injection drug users much more often had a regular partner and less often Am J Epidemiol Vol. 144, No. 8, 1996 used condoms with casual partners. For public health, it is important to realize that female injection drug users and their partners were and still are at increased HTV-risk via sexual transmission, because the magnitude of the sexual risk reduction was not substantially different for female and male injection drug users.
In summary, the sexual risk reduction was caused by a decrease in having noncommercial partners, an increase in condom use that has led to nonrandom condom use, and nonrandom mixing. It is not clear if nonrandom mixing is the result of intentional behavior change in order to reduce the risk to acquire or transmit HTV infection. Data on nonrandom condom use and nonrandom mixing should be incorporated into mathematical models forecasting the HTV epidemic to prevent overestimation of future spread of HTV infection. Nonrandom condom use was also reported in a study in New York (33) , where condom use was highest in relationships with HIV-positive injection drug users and in relationships with non-injection drug users. Some previous studies showed that risk reduction with noncommercial partners (4, 34) and commercial partners (5, 13) mainly occurred via an increase in condom use and not by a decrease in the number of partners.
Our finding of a relatively low risk for heterosexual spread of HTV within this group of Amsterdam injection drug users and from injection drug users to the general population is in concordance with the findings of other studies. In Amsterdam, the spread of HIV in the general population has remained very limited (35, 36) . Furthermore, in our cohort study, the HTV prevalence among heterosexual drug users without a history of injection is low: of 89 females, two (2.2 percent) were HTV-infected, and, of 88 males, one person (1.1 percent) was infected.
Because of the nature of our data, some remarks on the methodology are required in order to facilitate proper interpretation of our results. In our open cohort study, new recruits enter the cohort each year and a relatively small number are lost to follow-up, resulting in a higher mean number of cohort visits in time. Participation in the study itself may change the behavior of the participants due to both induced behavioral change (e.g., owing to the counseling component of our study) and a possible increase in socially desirable answers (i.e., participants may become more reluctant to admit the same risk behaviors at subsequent visits). Indeed, a higher number of cohort visits was strongly associated with lower levels of risk behavior. The relatively small number of new recruits per year did not permit a separate analysis. In addition, injection drug users who have received a positive test result exhibited the main risk reductions, and they may have been more likely to give socially desirable answers. To make our results more generalizable to Amsterdam as a whole, we have at least partially eliminated the effect of participation in the study itself on sexual risk behavior by adjustment for the variable number of study visits. A previous study within our cohort among prostitutes who used drugs (23) , in which diagnosed and self-reported episodes of sexually transmitted diseases were compared, showed that underreporting was not associated with knowledge of HTV-seropositivity. The present study suggested validity of the answers, because the declines in self-reported inconsistent condom use were comparable among participants who knew they were HIV-positive and HTV-negative with HTV-discordant regular partners; for both groups, this decreased to 15 percent. It has to be kept in mind that, in contrast to the adjusted trends in sexual risk behavior, the absolute levels of this behavior in our study population are probably an underestimate of levels in Amsterdam as a whole, because risk behavior strongly declined with higher number of follow-up visits.
After stratification for some number of follow-up visits, trends in calendar time may still be biased by an increase in socially desirable answers owing to a change in norms and attitudes against sexual risk behavior in society at large. However, we think it is very unlikely that such an increase, if it exists, would be large enough to explain the large declines in risk behavior.
The present study provides further indications for the effectiveness of HTV testing and counseling in reducing sexual risk behavior with noncommercial partners. Next to counseling, the testing component appears to be important, because the major risk reductions were observed among couples with a regular relationship who knew that their serostatus was discordant. HTV-testing and counseling seems most effective in high-risk relationships. Therefore, testing of regular partners of injection drug users should be encouraged. If we consider that approximately 2-3 percent of injection drug users seroconvert every year (20) , it appears important to offer HTV-negative injection drug users an HTV test on a regular basis.
A continuous risk reduction was observed among couples with discordant serostatus. Therefore, it may take a long time before the maximum effect of HIV testing and counseling is reached. Given that injection drug users in our study are repeatedly interviewed, tested, and counseled, long-term repeated interventions may be required to achieve a large risk reduction.
Previous studies in Amsterdam and elsewhere have shown that testing and counseling was strongly associated with significantly lower levels of injection risk behavior (10, 17) and commercial sexual risk behavior Am J Epidemiol Vol. 144, No. 8, 1996 
